FLAMMINI, Lisa
 Distribuzione geografica
Continente #
NA - Nord America 4.510
AS - Asia 2.446
EU - Europa 2.419
SA - Sud America 317
AF - Africa 136
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 9.835
Nazione #
US - Stati Uniti d'America 4.411
SG - Singapore 944
CN - Cina 854
IT - Italia 480
FI - Finlandia 415
IE - Irlanda 381
SE - Svezia 361
BR - Brasile 247
DE - Germania 236
HK - Hong Kong 192
VN - Vietnam 166
UA - Ucraina 114
NL - Olanda 113
TR - Turchia 90
ZA - Sudafrica 79
GB - Regno Unito 75
CA - Canada 63
IN - India 62
FR - Francia 61
RU - Federazione Russa 50
CI - Costa d'Avorio 39
BE - Belgio 31
BD - Bangladesh 28
AR - Argentina 27
PL - Polonia 21
MX - Messico 19
JP - Giappone 17
CZ - Repubblica Ceca 16
ES - Italia 16
KR - Corea 15
ID - Indonesia 14
AT - Austria 13
EC - Ecuador 10
PK - Pakistan 10
RO - Romania 9
PY - Paraguay 8
CH - Svizzera 7
IQ - Iraq 7
VE - Venezuela 7
CO - Colombia 6
NP - Nepal 6
EU - Europa 5
MY - Malesia 5
UZ - Uzbekistan 5
BO - Bolivia 4
CR - Costa Rica 4
IR - Iran 4
JO - Giordania 4
PA - Panama 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
EG - Egitto 2
HU - Ungheria 2
KZ - Kazakistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
CL - Cile 1
CM - Camerun 1
DZ - Algeria 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 9.835
Città #
Dallas 1.563
Singapore 507
Ashburn 405
Chandler 398
Dublin 380
Santa Clara 238
Beijing 226
Ann Arbor 222
Parma 197
Hong Kong 191
Dearborn 149
Jacksonville 145
Boardman 119
New York 97
Munich 84
Shanghai 83
Johannesburg 78
Nanjing 78
Izmir 73
Ho Chi Minh City 70
Los Angeles 61
Princeton 60
Hefei 52
Wilmington 40
Abidjan 39
Bremen 35
Milan 35
Groningen 33
Hanoi 32
Helsinki 31
Brussels 30
Chicago 30
Toronto 30
San Mateo 29
Bangalore 27
Buffalo 26
Kunming 26
Des Moines 25
São Paulo 24
Moscow 23
Guangzhou 22
Hebei 22
Jinan 22
Columbus 21
Shenyang 20
Nanchang 19
Marseille 18
Changsha 17
Houston 17
London 17
Seattle 17
Fremont 16
Turku 16
Bologna 15
Council Bluffs 15
Montreal 15
Stockholm 15
Tianjin 15
Tokyo 15
Norwalk 13
Redmond 13
The Dalles 13
Warsaw 13
Brno 12
Jakarta 12
Jiaxing 12
Nuremberg 12
Brooklyn 11
Manchester 11
Seoul 11
Denver 10
Reggio Emilia 10
Chennai 9
Montegaldella 9
Ottawa 9
Rio de Janeiro 9
Amsterdam 8
Boston 8
Grafing 8
Hangzhou 8
Mexico City 8
Modena 8
Poplar 8
Rome 8
Vienna 8
Woodbridge 8
Atlanta 7
Curitiba 7
Redwood City 7
Zhengzhou 7
Ankara 6
Brescia 6
Düsseldorf 6
Frankfurt am Main 6
Lanzhou 6
Orem 6
Phoenix 6
Porto Alegre 6
Pune 6
Redondo Beach 6
Totale 6.682
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.634
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 229
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 220
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 201
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 189
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 186
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 186
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 170
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 169
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 158
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 157
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 156
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 156
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 151
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 149
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 148
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 148
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 146
Antitumoral effect of a nanotechnology-based photodynamic therapy. 146
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 143
Hake fish bone as a calcium source for efficient bone mineralization 143
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 139
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 139
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 138
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 137
Analgesic activity of new hybrid muscarinic agonists in mice 132
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 131
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 130
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 128
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 125
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 125
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 125
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 124
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 123
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 121
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 121
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 121
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 118
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 117
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 116
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 115
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 114
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 114
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 110
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 108
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 108
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 105
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way 99
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 98
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 97
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 97
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 96
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 93
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 92
EphA2-ephrinA1 system in acute mesenteric inflammation due to ischemia-reperfusion in mice 92
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 91
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 90
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 87
Novel potent N-Methyl-d-Aspartate (NMDA) receptor antagonists or s1 receptor ligands based on properly substituted 1,4-dioxane ring 86
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 85
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 85
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors 77
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 74
New selective PDE4D inhibitors devoid of sedative effects in mice 70
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis 69
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice 66
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 63
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 61
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions 12
Totale 9.949
Categoria #
all - tutte 30.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 37 56 19 68 21 56 19
2021/2022391 21 16 25 48 24 17 32 32 18 27 13 118
2022/20231.393 168 170 84 106 129 154 30 63 407 14 53 15
2023/2024656 23 54 12 29 43 143 67 36 24 37 70 118
2024/20251.765 84 87 114 124 188 196 74 68 188 152 161 329
2025/20263.660 417 624 1.510 418 598 93 0 0 0 0 0 0
Totale 9.949